4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (0874) operates in the Medical Distribution industry and is headquartered in Guangzhou, China with about 26,365 employees. Its market capitalization is roughly HK$21 billion. In the fiscal year ended 2025-12-31, 0874 reported CNY 77.7B in revenue and CNY 3.0B in net income.
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited engages in the pharmaceutical and healthcare industry in the People's Republic of China and internationally.
Interactive charts & full statements → Open the 0874 valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | CNY 77.7B | CNY 75.0B | CNY 75.5B | CNY 70.8B | — |
| Gross Profit | CNY 12.6B | CNY 12.5B | CNY 14.2B | CNY 13.3B | — |
| Operating Income (EBIT) | CNY 3.5B | CNY 3.8B | CNY 4.9B | CNY 4.5B | — |
| Net Income | CNY 3.0B | CNY 2.8B | CNY 4.1B | CNY 4.0B | — |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | CNY 18.8B | CNY 23.3B | CNY 16.1B | CNY 19.4B | CNY 22.5B |
| Gross Profit | CNY 2.5B | CNY 4.7B | CNY 1.8B | CNY 3.1B | CNY 4.6B |
| Operating Income (EBIT) | CNY 464M | CNY 2.3B | (CNY 678M) | CNY 839M | CNY 2.3B |
| Net Income | CNY 312M | CNY 1.8B | (CNY 327M) | CNY 695M | CNY 1.8B |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dividends Paid | (CNY 1.6B) | (CNY 2.3B) | (CNY 1.6B) | (CNY 1.5B) | — |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Dividends Paid | (CNY 735M) | (CNY 90M) | (CNY 92M) | (CNY 656M) | (CNY 84M) |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | CNY 84.5B | CNY 81.7B | CNY 78.6B | CNY 74.7B | — |
| Total Liabilities | CNY 44.4B | CNY 43.9B | CNY 41.9B | CNY 41.0B | — |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 0874 viewer.
About TickerBase · Data methodology & sources · Privacy · Terms